The Daily Mail and Mail Online publish a personal account from Dr Ellie Cannon about a friend who says she has suffered debilitating chronic migraines for years and later experienced relief, which she attributes to Mounjaro.
Both articles describe the subject as having sought specialist treatments over much of her life for migraine symptoms. However, the pieces do not provide detailed medical trial evidence, study data, or independent verification of the cause-and-effect link between Mounjaro and migraine improvement. The reporting mainly centers on the anecdote and the author’s narrative, offering limited context on dosage, timeframe, prior therapies, or whether other factors could be involved.
Across the outlets, the framing is the same: it presents the story as an example of migraine improvement following Mounjaro use, without broader discussion of clinical guidelines or comparative outcomes for chronic migraine treatment.
